List of Tables
Table 1. Global Duchenne Muscular Dystrophy Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Duchenne Muscular Dystrophy Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Duchenne Muscular Dystrophy Market Competitive Situation by Manufacturers in 2023
Table 4. Global Duchenne Muscular Dystrophy Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Duchenne Muscular Dystrophy Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Duchenne Muscular Dystrophy Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Duchenne Muscular Dystrophy Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Duchenne Muscular Dystrophy Average Price (USD/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Duchenne Muscular Dystrophy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Duchenne Muscular Dystrophy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Duchenne Muscular Dystrophy, Product Type & Application
Table 12. Global Key Manufacturers of Duchenne Muscular Dystrophy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Duchenne Muscular Dystrophy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duchenne Muscular Dystrophy as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Duchenne Muscular Dystrophy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Duchenne Muscular Dystrophy Sales by Region (2019-2024) & (K Doses)
Table 18. Global Duchenne Muscular Dystrophy Sales Market Share by Region (2019-2024)
Table 19. Global Duchenne Muscular Dystrophy Sales by Region (2025-2030) & (K Doses)
Table 20. Global Duchenne Muscular Dystrophy Sales Market Share by Region (2025-2030)
Table 21. Global Duchenne Muscular Dystrophy Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Duchenne Muscular Dystrophy Revenue Market Share by Region (2019-2024)
Table 23. Global Duchenne Muscular Dystrophy Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Duchenne Muscular Dystrophy Revenue Market Share by Region (2025-2030)
Table 25. North America Duchenne Muscular Dystrophy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Duchenne Muscular Dystrophy Sales by Country (2019-2024) & (K Doses)
Table 27. North America Duchenne Muscular Dystrophy Sales by Country (2025-2030) & (K Doses)
Table 28. North America Duchenne Muscular Dystrophy Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Duchenne Muscular Dystrophy Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Duchenne Muscular Dystrophy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Duchenne Muscular Dystrophy Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Duchenne Muscular Dystrophy Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Duchenne Muscular Dystrophy Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Duchenne Muscular Dystrophy Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Duchenne Muscular Dystrophy Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Duchenne Muscular Dystrophy Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Duchenne Muscular Dystrophy Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Duchenne Muscular Dystrophy Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Duchenne Muscular Dystrophy Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Duchenne Muscular Dystrophy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Duchenne Muscular Dystrophy Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Duchenne Muscular Dystrophy Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Duchenne Muscular Dystrophy Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Duchenne Muscular Dystrophy Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Duchenne Muscular Dystrophy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Duchenne Muscular Dystrophy Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Duchenne Muscular Dystrophy Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Duchenne Muscular Dystrophy Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Duchenne Muscular Dystrophy Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Duchenne Muscular Dystrophy Sales (K Doses) by Type (2019-2024)
Table 51. Global Duchenne Muscular Dystrophy Sales (K Doses) by Type (2025-2030)
Table 52. Global Duchenne Muscular Dystrophy Sales Market Share by Type (2019-2024)
Table 53. Global Duchenne Muscular Dystrophy Sales Market Share by Type (2025-2030)
Table 54. Global Duchenne Muscular Dystrophy Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Duchenne Muscular Dystrophy Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Duchenne Muscular Dystrophy Revenue Market Share by Type (2019-2024)
Table 57. Global Duchenne Muscular Dystrophy Revenue Market Share by Type (2025-2030)
Table 58. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Type (2019-2024)
Table 59. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Type (2025-2030)
Table 60. Global Duchenne Muscular Dystrophy Sales (K Doses) by Application (2019-2024)
Table 61. Global Duchenne Muscular Dystrophy Sales (K Doses) by Application (2025-2030)
Table 62. Global Duchenne Muscular Dystrophy Sales Market Share by Application (2019-2024)
Table 63. Global Duchenne Muscular Dystrophy Sales Market Share by Application (2025-2030)
Table 64. Global Duchenne Muscular Dystrophy Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Duchenne Muscular Dystrophy Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Duchenne Muscular Dystrophy Revenue Market Share by Application (2019-2024)
Table 67. Global Duchenne Muscular Dystrophy Revenue Market Share by Application (2025-2030)
Table 68. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Application (2019-2024)
Table 69. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Application (2025-2030)
Table 70. Sarepta Therapeutics Corporation Information
Table 71. Sarepta Therapeutics Description and Business Overview
Table 72. Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. Sarepta Therapeutics Duchenne Muscular Dystrophy Product
Table 74. Sarepta Therapeutics Recent Developments/Updates
Table 75. PTC Therapeutics Corporation Information
Table 76. PTC Therapeutics Description and Business Overview
Table 77. PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. PTC Therapeutics Duchenne Muscular Dystrophy Product
Table 79. PTC Therapeutics Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Pfizer Duchenne Muscular Dystrophy Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Bristol-Myers Squibb Corporation Information
Table 86. Bristol-Myers Squibb Description and Business Overview
Table 87. Bristol-Myers Squibb Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. Bristol-Myers Squibb Duchenne Muscular Dystrophy Product
Table 89. Bristol-Myers Squibb Recent Developments/Updates
Table 90. Italfarmaco Corporation Information
Table 91. Italfarmaco Description and Business Overview
Table 92. Italfarmaco Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. Italfarmaco Duchenne Muscular Dystrophy Product
Table 94. Italfarmaco Recent Developments/Updates
Table 95. Santhera Pharmaceuticals Corporation Information
Table 96. Santhera Pharmaceuticals Description and Business Overview
Table 97. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Product
Table 99. Santhera Pharmaceuticals Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Duchenne Muscular Dystrophy Distributors List
Table 103. Duchenne Muscular Dystrophy Customers List
Table 104. Duchenne Muscular Dystrophy Market Trends
Table 105. Duchenne Muscular Dystrophy Market Drivers
Table 106. Duchenne Muscular Dystrophy Market Challenges
Table 107. Duchenne Muscular Dystrophy Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Duchenne Muscular Dystrophy
Figure 2. Global Duchenne Muscular Dystrophy Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Duchenne Muscular Dystrophy Market Share by Type in 2023 & 2030
Figure 4. Exondys 51 Product Picture
Figure 5. Emflaza Product Picture
Figure 6. Translarna Product Picture
Figure 7. Global Duchenne Muscular Dystrophy Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Duchenne Muscular Dystrophy Market Share by Application in 2023 & 2030
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Home Care
Figure 12. Global Duchenne Muscular Dystrophy Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Duchenne Muscular Dystrophy Market Size (2019-2030) & (US$ Million)
Figure 14. Global Duchenne Muscular Dystrophy Sales (2019-2030) & (K Doses)
Figure 15. Global Duchenne Muscular Dystrophy Average Price (USD/Dose) & (2019-2030)
Figure 16. Duchenne Muscular Dystrophy Report Years Considered
Figure 17. Duchenne Muscular Dystrophy Sales Share by Manufacturers in 2023
Figure 18. Global Duchenne Muscular Dystrophy Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Duchenne Muscular Dystrophy Players: Market Share by Revenue in 2023
Figure 20. Duchenne Muscular Dystrophy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Duchenne Muscular Dystrophy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Duchenne Muscular Dystrophy Sales Market Share by Country (2019-2030)
Figure 23. North America Duchenne Muscular Dystrophy Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Duchenne Muscular Dystrophy Sales Market Share by Country (2019-2030)
Figure 27. Europe Duchenne Muscular Dystrophy Revenue Market Share by Country (2019-2030)
Figure 28. Germany Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Duchenne Muscular Dystrophy Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Duchenne Muscular Dystrophy Revenue Market Share by Region (2019-2030)
Figure 35. China Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Duchenne Muscular Dystrophy Sales Market Share by Country (2019-2030)
Figure 46. Latin America Duchenne Muscular Dystrophy Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Duchenne Muscular Dystrophy Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Duchenne Muscular Dystrophy Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Duchenne Muscular Dystrophy by Type (2019-2030)
Figure 56. Global Revenue Market Share of Duchenne Muscular Dystrophy by Type (2019-2030)
Figure 57. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Type (2019-2030)
Figure 58. Global Sales Market Share of Duchenne Muscular Dystrophy by Application (2019-2030)
Figure 59. Global Revenue Market Share of Duchenne Muscular Dystrophy by Application (2019-2030)
Figure 60. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Application (2019-2030)
Figure 61. Duchenne Muscular Dystrophy Value Chain
Figure 62. Duchenne Muscular Dystrophy Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed